Image

Neuromodulation in Patients With Neuropathic Pain and Depression.

Recruiting
18 - 85 years of age
Both
Phase N/A

Powered by AI

Overview

High-frequency repetitive transcranial magnetic stimulation of the primary motor cortex has shown its effect on refractory neuropathic pain, and rTMS of the dorsolateral prefrontal cortex is commonly used for treatment-resistant depression.

The treatment for patients suffering from neuropathic pain and depression, concomitantly, still needs to be studied, as there are some specificities in both symptoms and brain functional MRI.

Description

This project is a cross-over study for these patients, including 4 sessions of either M1 or DLPFC rTMS, a wash-out period, followed by 4 sessions of the other stimulation site, to assess the efficiency of a DLPFC rTMS for neuropathic pain with a comorbid depression. Besides pain intensity and quality, patient's mood, quality of life, and catastrophizing will be assessed.

Eligibility

Inclusion Criteria:

  • Central or peripheral neuropathic pain
  • Chronic pain (present for more than 6 months) with intensity greater than or equal to 4/10 on the numerical scale
  • Pain present on a daily or near-daily basis (at least 4 days a week)
  • Patient not completely relieved by recommended drug treatments for first- and second-line neuropathic pain
  • Stable analgesic treatment (no new treatment or dosage adjustment) for at least one month, and will not need to be modified for the duration of the study.
  • Patient with a depressive episode characterized according to DSM V criteria
  • Indication for motor cortex rTMS by a neurologist
  • Patient can be followed for the entire duration of the study
  • Patient having received informed consent to participate in the study, and having co-signed a consent form with the investigator
  • Member or beneficiary of a social security scheme

Exclusion Criteria:

  • Industrial accident or litigation
  • Contraindication to rTMS or MRI (seismotherapy treatment since the previous month; epilepsy and/or history of epilepsy; history of head trauma; neurosurgical lesion; intracranial hypertension; intracerebral metal clip; piercing; pacemaker; insulin pump; metal prosthesis; pregnant or breast-feeding woman; claustrophobia)
  • Drug or psychoactive substance abuse
  • Neuropathic pain in the context of a progressive pathology (HIV, cancer, systemic disease disease)
  • Presence of other pain more severe than that justifying inclusion
  • Patient unable to understand informed consent
  • Patient unwilling or unable to stop treatments prohibited during the study
  • Patient participating in another research protocol involving a drug within the 30 days prior to inclusion
  • Patient deprived of liberty or under legal protection (guardianship, curatorship, safeguard of justice safeguard, family safeguard)
  • Minor patient

Study details

Neuropathic Pain, Depression

NCT06129890

Centre Hospitalier Universitaire de Saint Etienne

14 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.